Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
52,300
+1,900 (3.77%)
At close: Feb 6, 2026
72.89%
Market Cap2.00T +102.1%
Revenue (ttm)23.23B -27.3%
Net Income-13.14B
EPS-343.51
Shares Out38.26M
PE Ration/a
Forward PE290.56
Dividendn/a
Ex-Dividend Daten/a
Volume710,442
Average Volume510,924
Open54,000
Previous Close50,400
Day's Range49,850 - 54,300
52-Week Range24,500 - 66,000
Beta1.48
RSI57.10
Earnings DateMar 19, 2026

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements